Long-acting Steroid Contraception, Volume 2Daniel R. Mishell |
Contents
Depot Medroxyprogesterone Acetate | 1 |
Norethindrone Enanthate | 31 |
Monthly Injectable Contraceptives | 65 |
Copyright | |
6 other sections not shown
Common terms and phrases
acceptors acid amenorrhea baboons biodegradation bleeding patterns blood breast capsule carcinoma cervical clinical trial contraceptive steroids copolymers Copper T200 covered rods Cycloprovera decrease Deladroxate delivery systems device Diczfalusy discontinuation DL-PLA DMPA dosage dose drug delivery enanthate endometrial endometrium ester estradiol valerate estrogen evaluation excipient fertility formulations Fotherby function glucose glycolide Gynecol HDL-cholesterol homogeneous rods hormonal contraceptive human incidence increase inhibit injectable contraceptive intervals Johansson lactation levonorgestrel lipoprotein liver medroxyprogesterone acetate megestrol acetate menstrual cycle metabolism microcapsules Mishell monthly injectable months NET-EN ng/ml norethindrone norethisterone norethisterone oenanthate norgestrel NORPLANT observed Obstet ovarian ovulation plasma levels PLGA polymer pregnancy rate problems progesterone progestins progestogen progestogen-only rate of release regimen release rate reported serum levels SHBG side effects Silastic steroid steroidal contraceptives subdermal implants subjects TCu Nor TCu traception treatment users vaginal valerate 5 mg vitro vivo weight woman-years World Health Organization µg/day